Baird News

The Broken Heart Program

Professor Paul Bannon, Chair, The Baird Institute
Charles Perkins Centre – University of Sydney with researcher, Dr Laurencie Brunel

Recently we have developed a model for looking at mitral valve repair. This model will assist us with the maintenance of heart function when we replace a mitral valve (or any of the heart valves) in a patient. With this research project, we are looking into not only how well the replacement of the valve corrects the valve function, but how well it affects the heart function. Specifically, this will assist with the evaluation of new technology valves as we are able to examine how well they will perform by testing the different designs in this model that we have developed.

The fundamentals of this whole research program will lead into the most exciting component of it – individualised programs for patient correction. Based on the imaging of a patient’s heart, whether that be with echocardiography, a CT scan or an MRI, we are able to individualise the repair of a patient’s heart. When we know the fundamentals of heart function, what we do to a heart and what that in turn does to the heart, then we are able to individualise treatment for a particular patient. So, rather than utilising a valve off the shelf, we would have a valve that suited the patient exactly.

Another exciting component of the study is that we are planning to utilise a 3D bioprint of a heart whereby we take a patient’s scanned heart image, 3D print it and then place the 3D bioprint of the heart in our pump model so as to simulate the patient’s pump function. Using the information gained from the study on the best way to repair a particular patient’s heart, the proposed repair is then tested on the 3D printed model of the heart. As can be seen, the whole program is centred around individualisation rather than off-the-shelf correction, but it also forms a platform that allows us to test the technologies that are being produced by the big valve companies, in addition to allowing us to test our own designs. The work we are doing at present involves testing current techniques for valve repair and replacement and examining what impact they have on heart function, in addition to testing the impact the new technology valve replacements have on heart function.

Although this research has focused on the mitral valve, in the future, we intend to look at the tricuspid vale and the aortic valve, in addition to other areas of the heart so as to ascertain as much information as possible on heart and valve function.

The Biobanking Program

Dr Sean Lal, Director Sydney Heart Bank

Bio-banking in health care has evolved over the last few decades from simple biological sample repositories to complex and dynamic units with multi-organisational infrastructure networks. Together, the Baird Institute, RPAH and University of Sydney have established Australia’s first comprehensive Cardiovascular Surgery Bio-banking Program. Tissues are procured from aortic surgery, valvular surgery and myomectomy surgery (to treat hypertrophic cardiomyopathy) and cryopreserved at the state-of-the-art bio-banking facility at the University of Sydney. These tissues can then be used to facilitate translational research into the mechanisms of vascular disease and heart failure and hopefully lead to new therapeutic targets being discovered.

The figure adjacent shows how human heart tissue can be safely biopsied from the right atrium – only 2mg of tissue is needed to facilitate an analysis of some 4500 proteins in the human heart, which can then be undertaken in our research laboratories at the University of Sydney.

Scholarships and Grants Program

An Interview with Dr Mathew Doyle

Cardiothoracic registrar, Master of Philosophy candidate at the University of Wollongong and the recipient of a Baird Institute scholarship

What is your research topic?
My research project is entitled “eccentric cycling to address skeletal muscle dysfunction after cardiac surgery”. This research involves the development and construction of an eccentric cycling exercise bike, followed by testing the hypothesis that eccentric cycling can improve leg muscle function in patients after heart surgery.

What is the aim of your research?
The aims of my research are threefold:

  1. To perform a systematic review of the current literature into the safety and efficacy of aerobic exercise performed early in the postoperative period of patients following cardiac surgery.
  2. To develop and construct an eccentric cycling machine that can be used in a hospital at the bedside
  3. Performing eccentric cycling in patients following cardiac surgery and assess its effectiveness in improving leg muscle function prior to leaving hospital.

The systematic review was performed and identified that exercise performed early after cardiac surgery is safe and improves functional capacity. As there was no commercially available eccentric cycle machine that could be easily used to deliver the exercise for patients in a hospital ward, we then moved to designing and constructing a cycling machine that could be used for this purpose. A second study was then performed that described the design of this ergometer and demonstrated it was able to safely and repeatedly deliver the eccentric cycling exercise. The final stage of my research was for patients to perform eccentric cycling exercise bouts patients after coronary artery bypass surgery (CABG), and asses its impact on leg muscle function.

What is the potential impact of your research?
The big focus of this project is the type of cycling we are asking patients to do. My research uses “eccentric” cycling. In this type of cycling, a small motor in the exercise bike drives the pedals in a backwards direction, while the patients have to try and resist the pedals or slow the pedals down as they turn towards them. This type of exercise is very appealing for patients after heart surgery as the oxygen required to perform this type of exercise is much less than normal forward cycling. Patients can therefore work their leg muscles without stressing the heart and lungs.

Even simple activities such as walking can be too strenuous for some patients. The application of this novel form of exercise may provide elderly, frail and unwell patients with a means of improving their functional capacity at a fraction of the cardiac and metabolic requirements of more traditional exercise modalities. If we demonstrate this type of exercise to be effective and safe, it may be more widely applied to many other hospitalised populations.

How has the scholarship from The Baird Institute helped you?
The support of The Baird institute scholarship has been invaluable to my research. It has allowed me to access statistical software required to perform analysis of the captured data. It has provided me the opportunity to undergo training in database compilation while also allowing me to provide training to other health professionals required to assist in the study. Finally, the scholarship has allowed me to present the early findings of my research at both local and international conferences. Being face to face with other world leaders in this field of postoperative surgical care has provided me with a new network of experts and collaborators that will continue to drive future research.

I would like to express my sincere gratitude to all the supporters of the Baird Institute – it is you who has made my research possible.  I very much look forward to the opportunity of sharing the final results with you all once this project is completed.

A family’s history with aortic aneurysm disease

Alan Pope shares his story

In 2017 at the age of 38, Alan Pope was living in Perth and had an operation while there to remove a cancer from his back.   Following the operation, he underwent regular MRI and CT scans of the chest and was about to move to 6 monthly check-ups, when a radiographer noticed a size differential between his ascending and descending aorta.  He was referred to a cardiologist in Perth who advised that as he had an aneurysm of the aortic root, he would likely need an aortic root replacement. As he had no family support in Perth, Alan moved to Sydney, where many of his family resided.

Alan’s aortic root replacement surgery was carried out at Royal Prince Alfred Hospital in February 2019 with Professor Bannon as his surgeon.  Due to his age and the fact that his aortic valve was functioning normally, Alan was a good candidate for a “David Procedure” – a valve sparing aortic root replacement.   This procedure is named after a Canadian surgeon, Dr Tirone David, who initially conceived the operation. By preserving the patient’s aortic valve, the need for lifelong anticoagulation therapy is avoided.

6 days post-surgery Alan was discharged from hospital.  He completed his rehab and within a couple of weeks of the operation, he was walking up to 10kms per day.  He has maintained this regime and is benefiting immensely from the exercise and the weight loss.

Apart from high blood pressure, Alan had no indication that he might have an issue with his heart, however, when asked if he notices a difference now, he commented that he did not realise how much of a struggle it really was before! Professor Bannon explains that it is as a result of research that we are able to decide when the best time is to operate on patients with an aortic aneurysm BEFORE the aorta dissects.  When dissection happens a person’s chance of survival is greatly diminished. Thanks to the support of our donors and their investment in our research, the mortality rate for people with an aortic aneurysm has significantly reduced.

Alan comes from a family with a history of aneurysms.  In 1955, doctors found a dangerous aneurysm on the abdominal aorta of his great grandfather, Mr Leslie George Neale, and so at the age of 66 his grandfather underwent the first operation of its kind.  Because there were no artificial aortic grafts in 1955, a suitable donor graft from a deceased person’s abdominal aorta had to be found. Many hours were spent planning the operation.  One of the major concerns was how to keep Alan’s grandfather alive for the 12 or 13 hours required for a grafting operation of this kind.  After he was given his anaesthetic, Mr Neale was wrapped in ice until his body temperature dropped to 29 degrees. The purpose of doing this is reducing the body temperature greatly reduces the body’s need for blood. The diseased part of the artery was removed, and the donor graft was put in place.  The operation lasted 12 hours.

In 1989, at the age of 42, Alan’s father, Leslie John Pope, also had an aneurysm and suffered an aortic dissection in the posterior wall of the ascending aorta.  Alan was just 10 years old and was watching his father replace a gear box under the car when it happened. Alan’s Dad asked him to go and get him a cup of tea but when his father stood up, he collapsed. Paramedics were called and he was rushed to Prince Henry Hospital in Randwick.  He required a total aortic root reconstruction along with aortic valve replacement surgery and received a synthetic graft (made of Dacron). He was discharged from hospital almost a month after his operation.

The type of surgery that Alan himself had would not have been possible in 1955 as the heart-lung machine was not in widespread use until 1964.  In 1954 the machine was introduced into Australia and was used at Royal Prince Alfred Hospital with children, however its use with adults did not commence until 1957.

When Alan’s grandfather was operated on in 1955, as the heart-lung machine was not available, the only way to do his type of surgery in the safest way possible at the time, was to cool the body down by putting the patient on ice.  The mortality rate for this procedure was 50%, whereas now due to the heart lung machine, the rate of mortality for Alan’s David Procedure at RPAH is basically 0% for elective patients (those patients choosing when to have their surgery as opposed to those who come into the emergency department as a result of a cardiac arrest or an aortic dissection) while the mortality rate for a standard aortic root reconstruction is .5%.  Significantly different procedures and mortality rates, 65 years apart.

Today, the length of stay in hospital is vastly different for those patients who have elective aortic root surgery (as Alan and his grandfather had).  Patients are admitted to hospital on the day of their surgery and are discharged 6 or 7 days later.  Leslie Neale in 1955, on the other hand, was in hospital for one month which was commonplace at the time.

Aortic dissections would not have been operated on back in 1955 when Alan’s grandfather was alive, so Leslie was fortunate that he did not suffer a dissection.  In 1989 when Alan’s father had the dissection, approximately 50% of patients would not have made it to hospital in time and for the ones that did, the mortality rate would have been between 30 and 40%, with the best cardiac units getting that rate down to around 25%.  Today we have managed to reduce that figure to about a 10% overall mortality rate for surgeries post an aortic dissection, as a result of the development of more refined strategies for dealing with the complications of a dissection.

Furthermore, we have been more aggressive in our treatment than previously, we carry out far more extensive surgery to prepare for future problems and there have been significant improvements in surgical strategies which have vastly decreased the operative risk.  Finally, our research has enabled us to predict people’s risk of dissection and therefore decide when the optimum time for surgery is. Alan’s surgery is a case in point, we operated on him before he dissected and with the support of you, our donors, we hope in the future to be able to avoid the passage of this disease onto the next generation.

Alan has a young family himself and, especially with his family history of heart problems, he is telling his story for them.  He is keen to raise awareness and funds to provide more research into aortic aneurysm disease, so that other families do not have to go through what he has endured.  Operating techniques have changed dramatically since the 1950s and the funding of our supporters has enabled significant innovation and improvements.

Introducing our newest staff member

Cassandra Malecki, Research Assistant, The Baird Institute

I grew up in Sydney and completed a Bachelor of Medical Science at the University of Sydney, majoring in pathology. I completed my honors year in the Aortic Research Group at the Charles Perkins Centre at the University of Sydney, under Associate Professor Brett Hambly and Professor Richmond Jeremy.  The Aortic group has a focus on investigating various factors that may alter the severity of aneurysms of the thoracic aorta, particularly in patients with the genetic connective tissue disorder, Marfan Syndrome. After a very successful and enjoyable honours’ year, I decided to continue with a PhD in the same group and earlier this year submitted my PhD thesis which is currently under examination.

I was fortunate enough to be offered a job as a research assistant with The Baird Institute in the Cardiovascular group (headed by Dr Sean Lal, Professor Paul Bannon and Professor Richmond Jeremy), to continue my research journey in the cardiovascular field, with a particular interest in heart failure and cardiac aging. Along with assisting with projects and experiments that are currently underway in the Lal lab, a major part of my role involves collecting precious human heart and aortic tissue samples and managing the Sydney Heart Bank database. Throughout my PhD, I spent a lot of time collecting human aortic tissue which I was lucky enough to then use throughout my research projects and therefore I am very excited to still be involved in managing such an important biomedical research resource that is the Sydney Heart Bank.

This is another important investment in the team which supports the high-impact research conducted by our researchers.   Our wonderful supporters have made this investment possible.

Modern Cardiac Surgery

Professor Martin Misfeld, Co-Director of Research, Cardiothoracic Department, RPAH
Senior Consultant, University Department for Cardiac Surgery, Heart Centre, Leipzig

It was in Frankfurt, Germany, when Ludwig Rehn performed the first documented heart operation on the 9th of September 1896. He closed a hole in the heart of Wilhelm Justus, who was injured in a knife attack. Since then, cardiac surgery has undergone tremendous developments.

Modern cardiac surgery includes less invasive procedures. With a minimally invasive approach, heart valves can be repaired or replaced, and coronary artery bypass surgery can be performed. The aortic valve for example can be operated on via a small incision in the upper right chest.  Access to the mitral and tricuspid valve in contrast, is performed by through the space between the ribs on the right side of the chest.  These procedures can also be performed with the support of a robot, which has already been introduced at Royal Prince Alfred Hospital. In selected patients, Coronary Artery Bypass Grafting (CABG) can be done through a small incision on the left side of the chest. This procedure is performed on the beating heart. In almost all CABG procedures, it is possible to operate without the use of the heart-lung-machine on the beating heart. This technique is called off-pump coronary artery bypass surgery (OPCAB). It has the advantage of avoiding any manipulation of the aorta and as a result reducing the risk of perioperative stroke.

All modern techniques result in less trauma during surgery and patients recover much faster from the procedure. It is important to know, that each technique requires adequate training and expertise.

The cooperation between the Department of Cardiothoracic Surgery at Royal Prince Alfred Hospital and the Leipzig Heart Center, Europe`s number one cardiac centre, aims to expand these procedures in a variety of ways:

  1. By introducing specific techniques for the benefit of the patients by experienced surgeons,
  2. By educating young surgeons in these techniques eg. lectures, wet lab courses, surgical assistance,
  3. By evaluating clinical results of these procedures with cooperative research projects and finally
  4. By further improving these techniques, developing specific instruments and cooperating national and internationally on different levels.

Today, modern cardiac surgery can offer each patient individualized treatment with optimal surgical results, fast recovery and excellent long-term outcomes. It is important research that has taken place over the years that has got us to where we are today.

Podcast: Let’s talk robotics with Professor Paul Bannon

Joining me in today’s episode is Professor Paul Bannon. Paul is an adult cardiothoracic surgeon of international standing with clinical appointments at Royal Prince Alfred, Concord, Strathfield Private and Macquarie University Hospitals.

At Royal Prince Alfred Professor Bannon is the Head of Department of Cardiothoracic Surgery, Co-Chair of the Institute for Academic Surgery, Director of the Robotic Training Institute and the current President of the Medical Officers Association. At the University of Sydney, he holds the inaugural Professorial Chair of Cardiothoracic Surgery and the Bosch Chair of Surgery. He is also the current Head of the Discipline of Surgery for the Sydney Medical School and the Academic Director of the newly opened Translational Research Facility or Hybrid Theatre at the Charles Perkins Centre. He is the Chairman of The Baird Institute for Applied Heart and Lung Surgical Research. Professionally he is the immediate Past President of the Australian and New Zealand Society of Cardiothoracic Surgeons (ANZSCTS) and in that role serves on the steering Committee for the ANZSCTS National Cardiac Surgical Database, the National TAVI Accreditation Committee and is the Cardiac Surgical Chair of the Medical Benefits Schedule review program. For the Ministry of Health NSW he has been in the role of Co-Chair of the Cardiac Devices Committee for the Agency of Clinical Innovation.

Professor Bannon graduated from the University of Sydney in 1987, completed a PhD from the same institution in 1998 and was awarded a FRACS (CTh) in 1998. He has a particular passion for translational research in the areas of congenital aortic and mitral valve disease, biomaterials and biocompatibility, limitation of blood product usage in cardiac surgery, the inflammatory response to bypass and the development of academic surgical careers. He has authored or co-authored more than 120 scientific papers, published in peer-reviewed journals. He is co-editor-in-chief of the Annals of Cardiothoracic Surgery, a Medline listed multimedia journal of cardiothoracic surgery. Professor Bannon has a reputation as the ‘surgeons surgeon’ and has particular expertise in surgery of the aortic root and arch, high-risk re-do surgery, total-arterial coronary artery bypass grafting and surgery for hypertrophic cardiomyopathy.

For more information go to Paul’s website at www.paulbannon.com.au or if you would like to contact Paul directly, pgbannon@gmail.com

Listen to the podcast here:

https://www.exaptec.com.au/podcast/2021/2/4/0drr1p4av9uc5u3x814y3x69vgb5w4

Rebecca Mason’s Perth to Rottness Island ocean swim

“Good morning Rebecca, this is the Australian Federal Police, can you please confirm your location?”

It was 5.45am, on Thursday 4th February, 2021 and I can officially say, that this was possibly the worst wakeup call I had ever received.  I was in Perth having begun my 2 weeks of self-isolation in order to make the cut-off to still swim the 20km Perth to Rottnest Island.

The event is the equivalent of swimming from the Sydney Harbour Bridge to Manly return, just over 60% of the English Channel (35km), while the running translation is 80km.

There are only 400 people who complete the swim as a soloist like myself, and 2000 relayers. There is a 60-80% success rate on the day itself due to many variables many of which are outside of your control:

  • Your team: You have to find a boat and kayaker to accompany you for both safety and feeding. There are always a handful of boats that breakdown on the day, as well as kayakers who forfeit due to exhaustion or seasickness – it really is luck of the draw.
  • Hypothermia: If you spend long enough in warm water, you still get cold. There is a hypothermia medical tent at the end to give a glimpse into how many people do suffer from it. The only strategy to manage this, is to put on as much body fat as you can, to starve off the cold. The other is to wear a full body suit (wetsuits are not permitted).
  • Nutrition: We generally eat every 30 minutes and the food is highly sugar based as your body needs to burn carbs for these types of endurance events – which is a shock to me as a paleo person of 5 years. My swim diet includes strawberry yoghurt, coke and lollies.
  • Swimmer-induced oedema: This is when the lungs fill with fluid and need draining.
  • Tongue swell: When the tongue swells and blocks the throat due to exposure from salt water.
  • Timing cut-off: There are markers at the 10k, 15km, 18km marks in the swim, each with times allocated to them – ie if you don’t meet the 15km mark by 2pm, you get disqualified from the swim. Although the timings seem lenient on paper, the weather conditions really determine your timing and performance on the day.
  • Currents: Swimming against a current, feels like pushing against a brick wall (literally), and when you stop to feed, you can get pushed hundreds of metres backwards in seconds. This is why it can take hours to move just 1km instead of the standard 20 minutes.
  • The Fremantle Doctor: No, he’s not actually a doctor, but he’s a famous wind. This wind is generally 25 knots (a light breeze is about 5 knots) and as the wind intensifies the waves get bigger, you then need to swim under water and wait to be pulled to the top of the wave to get a chance to breath (without the risk of inhaling too much water).

Suffice to say, there are a lot of factors to consider and risks to train for. Most people who undertake this swim, have about 15+ years’ swimming experience underneath their belt and generally weigh about 110kgs.

In my case, I had less than 2 years’ experience, with only 2km as my longest swim, recent aortic valve sparing surgery (courtesy of Professor Bannon) and I weighed 55kgs. I’m sure we can all agree, I had a lot of catching up to do. So instead of undertaking a 3-month training program to prepare for the 20km swim, I had to triple it, with a 9-month training regimen.

I began simulating what solo swimming feels like – just me, swimming alongside a kayaker (or a boat) – from June last year, and we’ve had several experiences on this steep learning curve, dealing with 48 knot winds, sharks, 30 bluebottle stings to name just a few.

I’m very pleased to share, that I completed the Rottnest swim after 9 hours and 42 minutes of swimming on the 20th February this year.

An Interview with Dr Kei Woldendorp

A big congratulations to one of our Scholarship recipients, Dr Kei Woldendorp, who has submitted the thesis for his MPhil and is currently awaiting allocation of examiners and marking. Below is an interview with Kei about his research, so you will be able to discover more about the work he did during his MPhil.


Cardiothoracic surgical registrar at RPAH, a Master of Philosophy candidate at University of Sydney and the recipient of a Baird Institute Scholarship

What is your research topic?

Neurological injury after transcatheter aortic valve Implantation (TAVI). My research looks at aortic valve intervention post-operative stroke and neurological outcome. I am looking at both open surgical and minimally invasive techniques in my research.

What is the aim of your research?

To investigate the incidence, causes, and potential treatments of stroke and other neurological injury after transcatheter aortic valve replacement. The goal of this research is first and foremost to improve guidelines for patient selection as these procedures and techniques continue to evolve in the future, as well as understanding how these patients progress after their procedure. Stroke remains a devastating although fortunately rare outcome for aortic valve intervention. By understanding the risk factors that underly stroke, we hope to improve patient selection into different pathways and streams of management for aortic valve surgery or intervention and in the rare instances where stroke does occur we hope to understand how patients may progress and how treatment may help in their post-operative recovery, to reduce their burden or their quality of life.

What is the potential impact of your research?

As transcatheter aortic valve replacements (TAVI) expand to include lower risk and younger patients it is imperative to understand neurological injury associated with this procedure. An understanding of the causes may allow clinicians to develop new strategies to prevent or treat complications more effectively. An overview of this phenomenon may also allow clinical indications to be defined for TAVI to balance benefits and risk compared to alternative treatments such as surgical aortic valve replacement.

A total of 11 publications have been created through the research into this topic. Seven have been published and four are currently under review for consideration of publication in peer reviewed journals. and will be submitted towards the end of the year for the award of the degree of Master of Philosophy at The University of Sydney.

How has your scholarship from The Baird Institute helped you?

I have been fortunate enough to have been supported by a scholarship from The Baird Institute throughout my research and it has really assisted me in gaining access to quite high powered statistical software and hardware to analyse the data that we have collected. It has also allowed me to present my research at conferences both locally and internationally enabling me to share my ideas with my peers. By disseminating these ideas we hope to garner more interest and start more research in this area to help improve patient outcomes and patient safety in the future. I thank all those generous supporters of The Baird Institute for giving me this great opportunity to attain an MPhil and do life-saving research.

Cutting edge technology propels cardiac surgery forward

Australian heart surgery breakthrough a boon for COVID-19 patients

[https://www.9news.com.au/national/coronavirus-heart-failure-new-breakthrough-help-patients-australia/2e71d1b4-ec7f-4226-b2cb-3c0787a79fde]

Australian experts have found a way to treat highly contagious COVID-19 patients for ailing hearts without moving them out of intensive care.

The world-first study has been fast-tracked for coronavirus patients, but could also be a game-changer for acute heart failure in general.
Experiments in the University of Sydney’s hybrid theatre made use of a 3D ultrasound probe threaded through the blood vessels to the heart.

“From there you can see the heart in intimate proximity,” University of NSW intensive care specialist Konstantin Yastrebov said.

Using the probe, researchers were able to guide the implant of the world’s smallest heart pump, a bridging device that allows the failing heart to recover.

“It can actually pump almost four litres of blood per minute,” Royal Prince Alfred Hospital head of cardiac surgery Professor Paul Bannon said.

There’s no need for x-ray machines, radiation or open surgery, which means highly contagious patients – such as those with COVID-19 – can receive complex treatment at the bedside without leaving intensive care.

A study out of Wuhan found 40 per cent of coronavirus deaths were attributed to heart failure.

The study was performed earlier this year, when the disease first exploded in China.

The project team is now writing a plan for clinical trials.

“The imperative was there to develop it more quickly for COVID, but it will have wider applications post-COVID I’m sure,” Professor Bannon said.

Stay in the loop

Subscribe to our Heart to Heart newsletter to keep up with the latest developments in heart and lung research from The Baird Institute.

Dr Sean Lal

BMedSci(Hons), MBBS(Hons), MPhil(Med), PhD(Med), FRACP

Dr Sean Lal is an Academic in the Faculty of Medicine and Health at the University of Sydney and a Consultant Cardiologist at Royal Prince Alfred Hospital, sub-specialising in heart failure and cardiac MRI. He is also the Chair of the Heart Failure Council for the Cardiac Society of Australia and New Zealand.

Sean completed his undergraduate degree in Medical Science with first class honours at the University of Sydney, receiving full academic scholarship. He pursued his graduate Medical Degree (MBBS) and a Master of Medicine by research (MPhil) at the University of Sydney, where he was awarded the Dean’s Scholarship, the Medical Foundation Scholarship and the University of Sydney Bercovici Medal. As a medical doctor, Sean completed all of his general and specialty clinical training at Royal Prince Alfred Hospital. During his cardiology training, he was awarded a National Churchill Fellowship to study mechanisms of cardiac regeneration at Harvard Medical School.

Sean has a clinical and research interest in heart failure. For his PhD in this field, he was awarded a combined National Health and Medical Research Council (NHMRC) and National Heart Foundation (NHF) Scholarship, as well as the NHMRC and Royal Australasian College of Physicians (RACP) scholarship for research excellence.

He was also awarded a Commonwealth Endeavour Postgraduate Fellowship to Harvard University and Massachusetts Institute of Technology (MIT), where he undertook proof of concept studies demonstrating the intrinsic regenerative capacity of the human heart following myocardial infarction; whilst also gaining clinical experience in acute heart failure management in the cardiac ICU at the Brigham and Women’s Hospital.

Sean is the Director of the Sydney Heart Bank at the University of Sydney, which is one of the largest biorepositories of cryopreserved human heart tissue in the world. He is the Head of the Cardiac Research Laboratory in the School of Medical Sciences at the Charles Perkins Centre, which focuses on basic science and translational research into human heart failure.

Dr Brian Plunkett

This content is currently being updated.

Dr Benjamin Robinson

Mr Benjamin Robinson is an adult cardiothoracic surgeon with a long association with The Baird Institute. Whilst a medical student, he completed honours research with the Baird on outcomes in early-stage non-small cell lung cancer, under the supervision of Professor Brian McCaughan. He was awarded a Baird Institute Fellowship for this work. He subsequently trained in cardiothoracic surgery at Royal Prince Alfred Hospital and was the inaugural Baird Institute – Stanford University exchange scholar. Mr Robinson later completed a cardiac surgery clinical fellowship at Bart’s Heart Centre in London. He then worked as a consultant cardiothoracic surgeon at St. James’s Hospital in Dublin, before returning to Sydney to take up appointments at Royal Prince Alfred, Concord Repatriation General and Strathfield Private Hospitals.

Mr Robinson has experience in the spectrum of adult cardiac surgery, including coronary, valvular and aortic disease, as well as in general thoracic surgery. He has specific clinical interest in minimal access aortic valve surgery, arterial coronary grafting and aortic surgery. He has completed postgraduate study at Cambridge University and has academic interests in surgical outcomes research and epidemiology.

Professor Tristan Yan

Dr Tristan Yan is the Head of Department of Thoracic Surgery at Chris O’Brien Lifehouse. Professor Yan graduated from the University of New South Wales (UNSW) with Bachelor of Science (Medicine), Bachelor of Medicine and Bachelor of Surgery. He also completed three postgraduate higher degrees, Master of Surgery (USyd), Doctor of Medicine (UNSW) and Doctor of Philosophy (UNSW). He was trained at Royal Prince Alfred Hospital and St Vincent’s Hospital in Sydney and then obtained Cardiothoracic Surgery Fellowship from the Royal Australasian College of Surgeons. Following advanced specialty fellowships in the United States, England, Scotland and Germany, he specializes in minimally invasive cardiovascular surgery, and minimally invasive thoracic surgery.

Professor Tristan Yan is dedicated to surgical innovations. He applies the latest pioneering techniques to minimize surgical trauma and access sites and thus achieves a more rapid and comfortable recovery for his patients. He first completed his general surgical fellowship with Paul Sugarbaker in the United States, one of the most prominent surgeons in the world. He was then closely trained by the pioneer of Minimally Invasive Thoracic Surgery, Mr. William Walker, in Edinburgh, where he mastered the technical expertise of video-assisted thoracoscopic surgery (VATS) to perform complex lung resections, such as lobectomy and segmentectomy.

Associate Professor Chris Cao

After completing his medical degree at the University of New South Wales with First Class Honours, Christopher attended his pre-internship at Yale University, USA. He scored 99/99 for his United States Medical Licensing Exam, and completed his Cardiothoracic surgical training in Sydney. Concurrently, Christopher completed his PhD degree with Sydney University, focusing on the surgical management of lung and pleural diseases.

After completing his surgical training with the Royal Australasian College of Surgeons, Christopher was invited to a Fellowship at the Memorial Sloan Kettering Cancer Centre in New York City, one of the largest cancer centres in the world. This was followed by a Fellowship in New York University, where he was asked to join the Faculty in the Department of Cardiothoracic Surgery. His fellowship was focused on robotic and minimally invasive thoracic surgery, treating lung cancers, mediastinal tumours, mesothelioma, and other lung-related diseases. During his 18-month Fellowship at MSKCC and NYU, Christopher was fortunate to work with some of the leading international surgeons, gaining invaluable clinical and academic experience.

With over 100 publications in international peer-reviewed journal articles and book chapters, A/Prof Cao has a keen interest in thoracic surgery, particularly the treatment of lung cancers through minimally invasive surgery. He has made more than 50 presentations in international meetings as a Faculty Member in Paris, New York, Edinburgh, Taipei, Sydney, and Guangzhou. Christopher has personally supervised students and residents from Sydney University, University of New South Wales, Cornell University and New York University.

He is a member of the Australian and New Zealand Society of Cardiac and Thoracic Surgery, and works as a Consultant Surgeon at Lifehouse, Royal Prince Alfred Hospital, Concord Hospital, Sydney Adventist Hospital, and Macquarie University Hospital.

Dr Mike Byrom

Dr Michael Byrom is a modern, innovative cardiothoracic surgeon with training and experience in New Zealand, Australia, the United Kingdom, and Italy. Particular areas of expertise include:

  • Truly minimally-invasive surgery to the aortic valve that avoids complete division of the breast bone (hemi-sternotomy, right anterior mini-thoracotomy); allowing faster recovery and return to normal activities
  • Mitral valve repair with excellent repair rates and outcomes – resulting from diverse training in France, Italy, and the United Kingdom
  • Avoidance of the need for anticoagulation through valve selection, valve repair, and surgical treatment of atrial fibrillation
  • Minimally-invasive lung resection, avoiding a large thoracotomy wound and enabling faster recovery and return to normal activities with reduced pain and discomfort
  • Sternal and rib titanium plate fixation of chronic non-united fractures
  • Performing these procedures while minimising risk of complications, allowing Dr Byrom to achieve world-class results for his patients

Dr Matthew Bayfield

Dr Matthew Bayfield is an extremely experienced cardiothoracic surgeon with a broad range of skills and special interests within his field. He has performed more than 6000 heart and lung procedures. Dr Bayfield has hospital appointments at Strathfield Private Hospital, Royal Prince Alfred Hospital and Concord Hospital. His surgical interests include:

  • Coronary artery surgery: Dr Bayfield is one of Australia’s busiest coronary surgeons; with particular focus on minimal access incisions, and use of in-situ bilateral internal mammary artery grafts for enhanced longevity of the benefit of coronary revascularization.
  • Aortic root and arch surgery: Dr Bayfield has been performing aortic root and arch surgery since 1995, when he completed a Cardiovascular Fellowship at the University of Virginia in the USA. His focus is on o minimal access incisions, short cardiopulmonary bypass times, and for arch surgery antegrade cerebral perfusion with cerebral oxygen saturation monitoring.
  • Surgery for emphysema / CAL: Dr Bayfield was trained in open lung reduction surgery whilst doing a fellowship at the University of Virginia in 1995. Since that time he has developed thoracoscopic techniques for the procedure, and since 2003 been an implanter of endobronchial valves as a minimally invasive alternative to surgery. With over 100 endobronchial valve case experience, and long term follow-up of these patients, he is one of Australia’s most experienced endobronchial valve proceduralist.
  • Correction of pectus defects: Dr Bayfield has a special interest in correction of both pectus and carinatum defects, with techniques including implantation of Nuss bar under video-assisted control, and open radical sternochondroplasty.Lung cancer surgery: Dr Bayfield has been in surgical partnershio with Professor Brian McCaughan since 1996, and was trained by him as a registrar. Prof McCaughan is Australia’s most experienced and prolific lung cancer surgeon, has published widely on many aspects of its treatment, and has been awarded Medal of the Order of Australia (AM) for services to health in respect to his work on malignant mesothelioma.
  • Pacemaker and defibrillator implantation: Dr Bayfield was trained in device implantation as a young surgeon in the 1980’s and has developed skills to ensure that a device can be safely and reliably implanted even in the most difficult case with minimal risk. He was trained in cardiac resynchronzation therapy techniques at the introduction of that technology. He has regular pacemaker and defibrillator implantation lists at Royal Prince Alfred Hospital, Strathfield Private Hospital, and Concord Hospital.
  • Surgical treatment for ischaemic cardiomyopathy: Dr Bayfield trained in heart and lung transplantation whilst at the University of Virginia. With this skill base he has been able to develop a multi-faceted approach to treat patients whose hearts have been damaged by coronary artery disease (heart attack). These therapies include coronary artery bypass, mitral valve repair, and implantation of CRT defibrillators.

Professor Paul Bannon

Professor Paul Bannon is an adult cardiothoracic surgeon of international standing with clinical appointments at Royal Prince Alfred Hospital, Concord and Strathfield Private Hospital. At Royal Prince Alfred Hospital Professor Bannon is the Head of Department of Cardiothoracic Surgery, Co-Chair of the Institute for Academic Surgery, Director of the Robotic Training Institute and the current President of the Medical Officers Association. At the University of Sydney, he holds the inaugural Professorial Chair of Cardiothoracic Surgery and the Bosch Chair of Surgery. He is also the current Head of the Discipline of Surgery for the Sydney Medical School and the Academic Director of the newly opened Translational Research Facility or Hybrid Theatre at the Charles Perkins Centre. He is the Chair of The Baird Institute for Applied Heart and Lung Surgical Research. Professionally he is the Past President of the Australian and New Zealand Society of Cardiothoracic Surgeons (ANZSCTS) and in that role serves on the steering Committee for the ANZSCTS National Cardiac Surgical Database, the National TAVI Accreditation Committee and is the Cardiac Surgical Chair of the Medical Benefits Schedule review program. For the Ministry of Health NSW he has been in the role of Co-Chair of the Cardiac Devices Committee for the Agency of Clinical Innovation.

Professor Bannon graduated from the University of Sydney in 1987, completed a PhD from the same institution in 1998 and was awarded a FRACS (CTh) in 1998. He has a particular passion for translational research in the areas of congenital aortic and mitral valve disease, biomaterials and biocompatibility, limitation of blood product usage in cardiac surgery, the inflammatory response to bypass and the development of academic surgical careers. He has authored or co-authored more than 120 scientific papers, published in peer-reviewed journals. He is co-editor-in-chief of the Annals of Cardiothoracic Surgery, a Medline listed multimedia journal of cardiothoracic surgery. Professor Bannon has a reputation as the ‘surgeons surgeon’ and has particular expertise in surgery of the aortic root and arch, high-risk re-do surgery, total-arterial coronary artery bypass grafting and surgery for hypertrophic cardiomyopathy.

Professor Richmond W. Jeremy

MB BS PHD FRACP FAHA FESC FCSANZ GAICD

Professor Richmond Jeremy’s medical and cardiology training were at the University of Sydney and Royal Prince Alfred Hospital.

His clinical research career includes a PhD on coronary physiology and a post doctoral research Fellowship at Johns Hopkins Hospital, Baltimore before returning to the University of Sydney and Royal Prince Alfred Hospital.

University of Sydney responsibilities have included service as Associate Dean Sydney, Medical School, Head of Central Clinical School and Pro Vice-Chancellor, Campus Infrastructure and Services.

Professional responsibilities have included service as Editor-in-Chief of Heart Lung and Circulation, membership of Boards on National Heart Foundation (NSW), Royal Australasian College of Physicians (Adult Medicine Division) and Cardiac Society of Australia and New Zealand.

Mr. Shaun Clyne

MA LLM (Syd)

Shaun is a corporate lawyer based in Sydney. He is the Australian Head of the Mergers & Acquisitions practice. He regularly advises on a wide range of corporate and securities law issues for public listed companies including takeovers, schemes of arrangement and capital raisings. He advises on Australian Stock Exchange compliance matters and regularly acts for both bidders and targets in connection with takeover bids and schemes of arrangement (hostile and friendly) for ASX-listed companies.

A leading practitioner in equity capital markets, Shaun has also advised numerous companies on their initial public offerings and capital raisings (rights issues, AREO’s, placements, employee share and options plans).

Shaun has presented at a variety of seminars and conferences and published several papers in his areas of specialisation.

His areas of expertise are mergers and acquisitions, corporate advisory and capital markets.

Ms. Joanne Wade

BEc LLB

Joanne Wade has been a plaintiff lawyer since her admission to the Supreme Court of NSW in 1996 and has worked in asbestos litigation for well over 18 years. Joanne is an Accredited Specialist in Personal Injury Law and prides herself on her communication with her clients and, on many occasions, her clients’ families. She understands the importance and need to handle all her cases with the utmost diligence and compassion. Joanne has acted for hundreds of people suffering from mesothelioma, lung cancer, asbestosis and asbestos related pleural disease. Her clients are everyday people who have worked hard all their lives and deserve justice. Joanne acted for Steven Dunning in his claim against BHP Billiton Limited in the Dust Diseases Tribunal of NSW (Dunning vBHP Billiton Limited [2014] NSWDDT 3). Mr Dunning suffered from malignant pleural mesothelioma and in a landmark decision; the court awarded Mr Dunning the highest amount for damages for pain and suffering in NSW. Joanne went on to represent Mr Dunning in the Appeal before the NSW Court ofAppeal where BHP’s appeal was unanimously dismissed (BHPBilliton Limited v Dunning [2015] NSWCA 55). Joanne has also successfully acted for the late Bevan McGrath in his claim against Allianz Australia Insurance Limited, for his condition of asbestos related pleural disease and ensured that case was resolved on a provisional damages basis. Mr McGrath went on to develop mesothelioma, one of only a small number of cases where he then brought a second claim for further damages because his first claim was resolved on a provisional basis. Joanne successfully acted for Mr McGrath in both his claims and the late Mr McGrath successfully received further damages in a judgment by the court (McGrath v Allianz AustraliaInsurance Limited [2011] NSWDDT). The judgement was upheld on appeal (Allianz Australia Insurance Limited v McGrath [2011]NSWCA 153).

“It is with great privilege to work with people suffering from asbestos illnesses, and the greatest satisfaction formed is securing a result for those people to help ease their suffering, and to know their families will be looked after.”Joanne takes great pride in the work Slater and Gordon have undertaken in representing victims of asbestos disease, unions and asbestos support groups, including the work of Ken Fowlie in 2004 who acted for the ACTU and asbestos support groups in negotiations with James Hardie to secure an agreement which will ensure current and future victims of asbestos –related diseases would be fully compensated for years to come.Joanne is a passionate advocate and one thing that separatesJoanne from other lawyers is perspective, with her own father being exposed to asbestos working at Cockatoo IslandDockyard, she is in the unique position of seeing it from both angles.“My clients are generally people who have worked hard all their lives, and are lovely people who deserve justice. I am glad to fight for that justice and to make a difference to their lives.”

Expertise

  • Asbestos Claims
  • Dust Disease Board Appeals
  • Dust Diseases Claims
  • Compensation Claims

Career History

  • Slater and Gordon since 2008 (practice group leader)
  • 2000-2007 Watkins Tapsell (partner)
  • 1996-2000 Watkins Tapsell (lawyer)
  • 1992-1995 NSW Crown Solicitors Office (paralegal clerk)

Professor Clifford F. Hughes

AO MBBS FRACS FACC FACS FCSANZ

Professor Cliff Hughes is President of the International Society for Quality in Health Care. Until March 2015 he was the Chief Executive Officer of the Clinical Excellence Commission, a statutory health corporation established in 2004 to build capacity and design programs to promote and support improvement in quality and safety for health services across NSW. He has been chairman or member of numerous Australian state and federal committees associated with quality, safety and research in clinical practice for health care services. He has held various positions in the Royal Australasian College of Surgeons, including Senior Examiner in Cardiothoracic Surgery and member of the College Council. In November 2015 the College bestowed upon him the highest award given to a Fellow in his lifetime, the Sir Hugh Devine Medal. He has received awards for his national and international work including an Alumni Award from the University of NSW. He has led five medical teams to China and has performed cardiac surgery in Hong Kong, Singapore, Malaysia, India and Bangladesh. In 1998, he was made an Officer in the Order of Australia (AO) in recognition of his contributions and “service to cardiac surgery, international relationships and the community”. In June 2014, the University of NSW conferred upon him the degree of Doctor of Science, its peak academic award.

Professor Jeffrey Braithwaite

BA, MIR (Hons), MBA, DipLR, PhD, FIML, FCHSM, FFPHRCP (UK), FAcSS (UK), Hon FRACMA, FAHMS

Professor Jeffrey Braithwaite, BA, MIR (Hons), MBA, DipLR, PhD, FIML, FCHSM, FFPHRCP (UK), FAcSS (UK), Hon FRACMA, FAHMS is Founding Director, Australian Institute of Health Innovation, Director, Centre for Healthcare Resilience and Implementation Science, and Professor of Health Systems Research, Faculty of Medicine and Health Sciences, Macquarie University. His research examines the changing nature of health systems, attracting funding of more than AUD$131 million (EUR€81.8 million, GBP£70.8 million).

He has contributed over 470 peer-reviewed publications presented at international and national conferences on more than 915 occasions, including 97 keynote addresses. His research appears in journals such as JAMA, British Medical Journal, The Lancet, BMC Medicine, BMJ Quality & Safety, and International Journal for Quality in Health Care. He has received numerous national and international awards for his teaching and research.

He is interested in the Anthropocene and the impact of human activity on human and species’ health, population and climate. He blogs at http://www.jeffreybraithwaite.com/new-blog/.

Further details are available at his Wikipedia entry: http://en.wikipedia.org/wiki/Jeffrey_Braithwaite.

Ms. Michelle Sloane

BA MA MBA CMAHRI MAPsS​

Michelle’s background is in psychology and human resources working for many years in senior executive positions at Westpac, IBM and Unilever. Twenty years ago she established a human resources management consulting practice, Diversity Management, and led that organisation for 16 years. Michelle has worked extensively in the areas of change management, organisational analysis and design, human resource management, program management, stakeholder engagement as well as leadership development and training.

Michelle has a Master of Business Administration from the University of Technology, a Master of Arts (Psychology) from the University of Sydney and a Bachelor of Arts from the University of New South Wales. In addition Michelle is a Graduate of the Institute of Company Directors (GAICD).

Michelle has also been a Councillor for the City of Willoughby in Sydney. During her time as Councillor and Deputy Mayor, she has worked tirelessly with the local community advocating across a range of local and state-wide issues. Her interest in local government was developed over many years as a very active volunteer in her local community.

Professor Paul G. Bannon

MBBS PhD FRACS

Professor Paul Bannon is the Chair of The Baird Institute for Applied Heart and Lung Surgical Research, a not-for-profit medical research institute established in 2001, to improve the outcomes and better the lives of those undergoing heart and lung surgery.

He is Head of Department, Cardiothoracic Surgery at Royal Prince Alfred Hospital, Sydney and holds the Chair of Cardiothoracic Surgery and the Bosch Chair of Surgery, University of Sydney. He has performed over 2500 adult cardiac surgical procedures ranging from coronary artery bypass to complex aortic root and arch reconstructions. He is President of the Australia and New Zealand Society of Cardiac and Thoracic Surgeons and is the Society representative to the Cardiac Surgery National Database. He is the Co-Chair of the Institute of Academic Surgery at RPAH where he also oversees the robotic surgical program. He heads the National MBS Taskforce Review for Cardiac Surgery and has held various positions in the Royal Australasian College of Surgeons and Royal Prince Alfred Hospital.

Professor Bannon’s teaching responsibilities are currently to all years of the Graduate Medical Program at Sydney Medical School, University of Sydney. He supervises local and international Doctorate, Masters and Honours students as well as international elective students. He is the Co Editor-in-Chief of The Annals of Cardiothoracic Surgery and a Director of the CORE Group for International Collaborative Research. Professor Bannon has published widely in books, journals and conference proceedings on cardiothoracic surgery, basic science and evidence based medicine.

He has a particular passion for translational research in the areas of congenital aortic and mitral valve disease, hypertrophic cardiomyopathy, biomaterials and biocompatibility, limitation of blood product usage in cardiac surgery, the inflammatory response to bypass and the development of academic surgical careers. He is a current Chief Investigator on NHMRC and NHF grants for biomaterials and congenital heart disease research as well as a current NHMRC CRE grant on mechanical circulatory support. His role in the CRE is to produce NHMRC Clinical Practice Guidelines and measure their dissemination, adoption and outcomes. He personally oversees more than $500,000 worth of research funding annually. His Department currently runs 16 clinical trials amongst many other laboratory and clinically based projects.